260 filings
Page 2 of 13
8-K
zskcurrfuq s9hqrosaz
10 Aug 23
Eton Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:15pm
8-K
to8j1l8sm567
5 Jul 23
Termination of a Material Definitive Agreement
4:15pm
8-K
z634xeyhw 0gys6hfdq
28 Jun 23
Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection
6:55am
8-K
5wh pfh1yexuh
15 Jun 23
Entry into a Material Definitive Agreement
4:18pm
8-K
prqmls7c598p 8uf
13 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
npj8y
11 May 23
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
4:15pm
8-K
3q4s eg8ars6uuc7yswe
10 May 23
Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution
6:50am
EFFECT
1np 7zm1mkma9d0uf
3 May 23
Notice of effectiveness
12:15am
CORRESP
67pnt rsff
1 May 23
Correspondence with SEC
12:00am
UPLOAD
8vd3s3s0 fe556
12 Apr 23
Letter from SEC
12:00am
S-8
lxcim 9kv
20 Mar 23
Registration of securities for employees
8:20pm
8-K
193mldehuegyer8 399
16 Mar 23
Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results
4:24pm
8-K
3ghy82nfl9qr
15 Mar 23
Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
7:00am
8-K
dsas2 yxnh7jm
13 Mar 23
Regulation FD Disclosure
6:50am
3
cw6fyfkq1xs bpllz
8 Mar 23
Eton Pharmaceuticals / David Krempa ownership change
2:39pm